Open AccessSoluMatrix®Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain
Author(s) -
Charles E. Argoff,
Bill McCarberg,
Jeff Gudin,
Srinivas Nalamachu,
Clarence L. Young
Publication year - 2016
Publication title -
pain medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 97
eISSN - 1526-4637
pISSN - 1526-2375
DOI - 10.1093/pm/pnw012
Subject(s) - diclofenac , medicine , celecoxib , placebo , opioid , anesthesia , adverse effect , analgesic , randomized controlled trial , surgery , alternative medicine , receptor , pathology
To evaluate opioid rescue medication usage and the opioid-sparing effect of low-dose SoluMatrix ® diclofenac developed using SoluMatrix Fine Particle Technology™ in a phase 3 study in patients experiencing pain following bunionectomy surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom